Testing effectiveness (Phase 2)Ended earlyNCT01251965What this trial is testingPhase l/II Study of Ruxolitinib for Acute LeukemiaWho this might be right forLeukemia M.D. Anderson Cancer Center 27
Early research (Phase 1)Ended earlyNCT00005787What this trial is testingPeripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphomaNeutropenia Northwestern University 3
Early research (Phase 1)Ended earlyNCT04553692What this trial is testingPhase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed CancersWho this might be right forSolid TumorColorectal CancerNon Hodgkin Lymphoma+5 more IGM Biosciences, Inc. 272
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07162571What this trial is testingThis is a Phase I/II Interventional, Open-label Treatment Study Designed to Evaluate the Safety and Efficacy of Anti CD 19/22 CAR- T Cells Immunotherapy for Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma.Who this might be right forAcute Lymphobkastic LeukemiaB Cell Lymphoma Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology 17
Testing effectiveness (Phase 2)UnknownNCT05809167What this trial is testingVenetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSCTWho this might be right forAllogeneic Hematopoietic Stem Cell TransplantationAcute Lymphoblastic Leukemia The First Affiliated Hospital of Soochow University 55
Testing effectiveness (Phase 2)Study completedNCT00763763What this trial is testingImatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL PositiveWho this might be right forLeukemia, Lymphocytic, AcutePhiladelphia ChromosomeBlast Crisis+1 more Assistance Publique - Hôpitaux de Paris 55
Early research (Phase 1)Looking for participantsNCT03326921What this trial is testingHA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell TransplantWho this might be right forJuvenile Myelomonocytic LeukemiaRecurrent Acute Biphenotypic LeukemiaRecurrent Acute Undifferentiated Leukemia+26 more Fred Hutchinson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT01116193What this trial is testingRepeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic LeukemiaWho this might be right forLeukemia, LymphoidPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma Institut de Cancérologie de la Loire 10
Early research (Phase 1)Study completedNCT01567709What this trial is testingAlisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaWho this might be right forAdult B Acute Lymphoblastic LeukemiaAdult T Acute Lymphoblastic LeukemiaAnaplastic Large Cell Lymphoma+32 more National Cancer Institute (NCI) 34
Very early researchLooking for participantsNCT06346912What this trial is testingCD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHLWho this might be right forAcute Lymphoblastic Leukemia,B-CellNon-hodgkin Lymphoma,B Cell Zhejiang University 20
Testing effectiveness (Phase 2)Ended earlyNCT00882206What this trial is testingPre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic LeukemiaWho this might be right forLeukemiaLymphoma Masonic Cancer Center, University of Minnesota 15
Early research (Phase 1)Study completedNCT00077558What this trial is testing3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Study completedNCT00036790What this trial is testingMotexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more University of Wisconsin, Madison
Not applicableStudy completedNCT00996047What this trial is testingS9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic CancersWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms SWOG Cancer Research Network 3,341
Testing effectiveness (Phase 2)Study completedNCT01789255What this trial is testingVorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more National Cancer Institute (NCI) 12
Not applicableStudy completedNCT00053157What this trial is testingSargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more Roswell Park Cancer Institute 10
Testing effectiveness (Phase 2)Study completedNCT00309907What this trial is testingEtanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChildhood Acute Lymphoblastic Leukemia in Remission+22 more Children's Oncology Group 39
Not applicableWithdrawnNCT01558778What this trial is testingMechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+100 more Roswell Park Cancer Institute
Very early researchNot Yet RecruitingNCT07196111What this trial is testingBAFFR CAR-T Treatment for Relapsed/Refractory B-cell TumorsWho this might be right forB Acute Lymphoblastic Leukemia/Lymphoma Guangzhou Bio-gene Technology Co., Ltd 12
Early research (Phase 1)Looking for participantsNCT06447987What this trial is testingHumanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic LeukemiaWho this might be right forRecurrent Acute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic Leukemia City of Hope Medical Center 24